Cite
HARVARD Citation
Kanaan, R. et al. (2023). Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients. JGH open. 7 (3), pp. 197-203. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kanaan, R. et al. (2023). Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients. JGH open. 7 (3), pp. 197-203. [Online].